Plc Glaxosmithkline

Insider Trading: Purchases
Symbol Price Amount Total Value Remaining Holdings Date Form 4
WVE $8.00 2,791,930 $22,335,440.00 16,775,691 2024-09-27 Filing
WVE $5.00 3,300,000 $16,500,000.00 13,983,761 2023-12-07 Filing
DBTX $18.00 150,000 $2,700,000.00 1,183,663 2021-02-17 Filing
GNCA $2.25 1,260,504 $2,836,134.00 4,626,389 2020-07-24 Filing
PAND $18.00 361,111 $6,499,998.00 2,248,304 2020-07-21 Filing
NKTX $18.00 833,333 $14,999,994.00 3,150,732 2020-07-14 Filing
TPTX $60.00 83,333 $4,999,980.00 2,253,660 2020-05-21 Filing
PRNB $28.00 357,142 $9,999,976.00 2,982,855 2019-10-18 Filing
TPTX $45.00 177,777 $7,999,965.00 2,170,327 2019-09-10 Filing
MORF $15.00 333,333 $4,999,995.00 2,633,772 2019-07-01 Filing
GNCA $3.50 1,857,142 $6,499,997.00 3,365,884 2019-06-24 Filing
BCYC $14.00 385,714 $5,399,996.00 1,915,275 2019-05-28 Filing
TPTX $18.00 325,000 $5,850,000.00 1,992,550 2019-04-22 Filing
PRNB $17.00 270,000 $4,590,000.00 2,625,713 2018-09-18 Filing
LQDA $11.00 148,818 $1,636,998.00 624,422 2018-07-30 Filing
SPRO $12.50 80,000 $1,000,000.00 1,934,006 2018-07-17 Filing
TBIO $13.00 269,230 $3,499,990.00 3,697,912 2018-07-02 Filing
SPRO $14.00 428,571 $5,999,994.00 1,854,006 2017-11-06 Filing
CRSP $14.00 66,500 $931,000.00 3,220,627 2016-10-24 Filing
TBPH $23,027,965.50 1,301,015 $29,959,728,534,982.50 9,644,807 2016-03-14 Filing